Literature DB >> 3859695

Risk factors for fibrocystic breast disease and its histopathologic components.

G S Berkowitz, J L Kelsey, V A LiVolsi, T R Holford, M J Merino, S Ort, T Z O'Connor, C White.   

Abstract

The relationship between various sociodemographic, reproductive, and other factors to the occurrence of fibrocystic breast disease was evaluated in a case-control study undertaken at five Connecticut hospitals from 1979 to 1981. The study groups comprised 590 women with biopsy-proven fibrocystic breast disease and 1,018 women with other surgical conditions. Among the premenopausal women, multivariate analysis suggested that high socioeconomic status, Jewish religion, low parity, a history of benign breast disease, a history of breast cancer in the mother or a sister, and low Quetelet index were associated with increased odds ratios (OR) for fibrocystic breast disease. Similar analysis for the postmenopausal women revealed increased OR for women with high socioeconomic status, a late age at menopause, and a history of benign breast disease. Current smokers as well as those who had had a tubal sterilization had significantly reduced odds of fibrocystic disease. There was no convincing evidence of linear trends according to degree of epithelial atypia for any of the variables considered. Although some variation in the OR emerged in the analysis according to selected histologic components, the results provided little evidence that women with biopsy specimens exhibiting gross cysts, sclerosing adenosis, papillary hyperplasia, or papillomatosis showed epidemiologic similarities with breast cancer patients.

Entities:  

Mesh:

Year:  1985        PMID: 3859695

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

Review 2.  Dietary prevention of breast cancer.

Authors:  D P Rose; J M Connolly
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

4.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

5.  Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.

Authors:  Yaqin Chen; Anthony Bekhash; Albert J Kovatich; Jeffrey A Hooke; Jianfang Liu; Leonid Kvecher; J Leigh Fantacone-Campbell; Edith P Mitchell; Hallgeir Rui; Richard J Mural; Craig D Shriver; Hai Hu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer.

Authors:  Y Minami; N Ohuchi; Y Taeda; A Fukao; S Hisamichi
Journal:  Jpn J Cancer Res       Date:  1998-02

7.  The comparison of the effect of flaxseed oil and vitamin E on mastalgia and nodularity of breast fibrocystic: a randomized double-blind clinical trial.

Authors:  Gholamali Godazandeh; Shahram Ala; Tahereh Madani Motlaq; Adeleh Sahebnasagh; Aliyeh Bazi
Journal:  J Pharm Health Care Sci       Date:  2021-01-06

8.  Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.

Authors:  Soley Bayraktar; Hongming Qiu; Diane Liu; Yu Shen; Angelica M Gutierrez-Barrera; Banu K Arun; Aysegul A Sahin
Journal:  Biomark Cancer       Date:  2015-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.